The corn snake, a captive-bred male weighing around 500 grams, had lived for twelve years in a carefully managed glass terrarium alongside a female conspecific. His owners provided ultraviolet B lighting on a ten-hour cycle, basking areas warmed to 32 degrees Celsius, night-time temperatures of 20 degrees, and humidity between 45 and 70 percent. He was fed two adult mice every two weeks, received no calcium or vitamin supplementation, and was never subjected to winter brumation. Despite this stable routine, the snake had never been examined by a veterinarian, and no prior medical problems had been reported.

The trouble began insidiously. For four months the snake showed progressively generalized lethargy, episodes of uncoordinated winding movements, clumsy climbing attempts, and a weakening righting reflex — the instinctive ability to flip upright when turned over. He had also been anorexic for three months and losing weight. The most striking sign emerged three weeks before presentation: a progressive swelling along the dorsal surface of the middle third of his body. Ten days before the clinic visit, the snake fell from a platform in his terrarium, after which his coordination deteriorated dramatically. When a physical examination revealed an approximately 15-centimeter firm, nodular mass along the back, together with a second firm mass palpable inside the body cavity, the veterinary team knew they were dealing with something serious.

Radiographs taken under manual restraint painted a grim picture. The images revealed segmented fusion of adjacent vertebrae extending over a total length of 20 centimeters, irregular bone contours consistent with osteophyte formation and remodeling, and lysis — destructive breakdown — of vertebral processes. Additional osteolytic lesions appeared in several vertebral processes behind the main lesion, and a longitudinal soft-tissue mass with its own opacity was visible ventral to the spinal damage. In short, something was aggressively eating away at and rebuilding the snake’s backbone from the outside in.

Ultrasound examination added a crucial piece of the puzzle. Using an 11-MHz linear probe with the snake in dorsal recumbency, the clinicians identified a 4 by 1.5 by 2 centimeter irregular, moderately vascularized mass associated with the liver. Doppler imaging quantified the blood supply to the lesion, confirming it was not a simple cyst or abscess but a living, growing structure. The combination of a destructive spinal process and a liver-associated mass strongly suggested that the snake was suffering from a malignant tumor that had already seeded a distant organ.

Given the snake’s cachectic body condition, his flaccid muscle tone, his severely reduced reflexes, and the advanced stage of the spinal disease, the prognosis was judged poor to grave. The owners elected euthanasia and consented to post-mortem sampling of both masses, though they declined to release the entire carcass for a full necropsy. That decision limited the scope of the investigation, but the tissue that was recovered proved diagnostically decisive.

Histopathology revealed a paravertebral neoplasm infiltrating the adjacent musculature and extending into the vertebral bones, causing multifocal osteolysis. Within the liver, multifocal round masses of varying size showed the same infiltrative growth pattern. The tumor cells were medium-sized spindle shapes, roughly 30 to 40 micrometers long, with indistinct borders, moderate amounts of eosinophilic cytoplasm, and large eccentric nuclei bearing prominent basophilic nucleoli. The cells displayed severe anisocytosis and anisokaryosis — marked variation in cell and nuclear size — and mitotic figures appeared at a rate of two to four per high-power field, with bizarre mitoses and zones of necrosis scattered throughout. Azan trichrome staining confirmed a collagen-containing stroma woven through the neoplasm.

Immunohistochemistry was then deployed to fingerprint the tumor. Antibodies targeting vimentin produced moderate, multifocal to coalescing cytoplasmic staining in both the paravertebral mass and the liver tumors, indicating a mesenchymal origin — the hallmark of a sarcoma. Cross-reactivity controls confirmed that the antibody panel worked reliably on snake tissue: cytokeratin labeled biliary epithelium, desmin labeled skeletal muscle and vessel walls, GFAP labeled spinal cord astrocytes, and periaxin labeled peripheral nerve. Critically, the tumor cells did not express desmin, alpha-smooth muscle actin, GFAP, or periaxin, which ruled out origins from skeletal muscle, smooth muscle, or peripheral nerve sheaths. Taken together, the findings pointed to a poorly differentiated, metastasizing fibrosarcoma — most likely arising in the paravertebral tissue and secondarily invading bone, though the authors acknowledge that a primary vertebral tumor extending outward is also plausible.

The case carries broader significance for reptile medicine. Neoplastic disease in snakes appears to be reported with increasing frequency, a trend attributed to longer captive lifespans, better diagnostic services, and more informed owners bringing animals to clinics. Multi-institutional surveys have found that the vast majority of snake neoplasms — between 78 and 86.6 percent — are malignant, with soft tissue sarcomas among the most common. Musculoskeletal neoplasia, however, remains rare, accounting for only 1.4 to 4.8 percent of all tumors in snakes. Metastatic spread has been documented in reptiles, with one large study detecting metastases in 12.7 percent of reptiles with neoplastic disease, and another reporting detectable metastases in 42.9 percent of snakes with cancer. Yet ante-mortem diagnosis of metastasis is seldom reported, largely because reptile patients tend to arrive at clinics with disease already at an advanced stage, so full cancer staging is rarely performed. The authors suggest that this practice likely underestimates the true rate of metastatic tumors in snakes.

The Hannover team also emphasizes a practical lesson for clinicians: neoplasia deserves a place on the differential diagnosis list for common vertebral disorders in snakes, alongside the infectious, nutritional, and traumatic causes that are more routinely considered. Radiography and ultrasonography, they note, can be genuinely useful in detecting possible metastatic spread before death, and advanced imaging such as computed tomography or magnetic resonance imaging could offer even greater clarity in future cases. Treatment options — surgery, radiotherapy, chemotherapy — exist in the literature, but standardized cancer protocols are not yet established for any reptile species, and one survey found that only about 27 percent of snakes with neoplastic disease received any treatment at all, often because they were presented too late. For this corn snake, euthanasia was the humane endpoint. But the detailed documentation of his illness adds a valuable data point to a small but growing body of knowledge, and the authors call for more published case reports to deepen understanding of disease processes and treatment regimens in snakes — animals whose cancers, like their biology, remain full of surprises.

Subject of Research: Malignant paravertebral sarcoma with hepatic metastases in a corn snake

Article Title: Malignant paravertebral sarcoma with concurrent hepatic metastases in a corn snake (Pantherophis guttatus)

Article References: Hetterich, J., Puff, C., & Pees, M. (2025). Malignant paravertebral sarcoma with concurrent hepatic metastases in a corn snake (Pantherophis guttatus). Veterinary Oncology, 2(1), Article 32. https://doi.org/10.1186/s44356-025-00046-z

Image Credits: AI Generated

DOI: 10.1186/s44356-025-00046-z

Keywords: corn snake, Pantherophis guttatus, sarcoma, spindle cell tumor, metastasis, vertebral disease, reptile oncology, fibrosarcoma, veterinary pathology, immunohistochemistry, herpetology, liver tumors